GSE158834 ADIPOR2 knockout HEK293 12 v 13 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE158834_ADIPOR2 knockout_HEK293_12_v_13_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE158834_ADIPOR2 knockout_HEK293_12_v_13_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE158834_ADIPOR2 knockout_HEK293_12_v_13_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE158834_ADIPOR2 knockout_HEK293_12_v_13_human_up.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

vesicle associated membrane protein 7

Gene

family with sequence similarity 106 member A

Gene

H2A clustered histone 11

Gene

H2A clustered histone 19

Gene

gametogenetin binding protein 2

Gene

GOLGA2 pseudogene 7

Gene

double homeobox A pseudogene 8

Gene

long intergenic non-protein coding RNA 2693

Gene

VPS9D1 antisense RNA 1

  • Gene

    H4 clustered histone 15


  • Gene

    vesicle associated membrane protein 7


  • Gene

    family with sequence similarity 106 member A


  • Gene

    H2A clustered histone 11


  • Gene

    H2A clustered histone 19


  • Gene

    gametogenetin binding protein 2


  • Gene

    GOLGA2 pseudogene 7


  • Gene

    double homeobox A pseudogene 8


  • Gene

    long intergenic non-protein coding RNA 2693


  • Gene

    VPS9D1 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.